409 related articles for article (PubMed ID: 28810904)
21. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
Atzema CL; Austin PC
Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
[TBL] [Abstract][Full Text] [Related]
22. Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope.
Dalgaard F; Pallisgaard JL; Numé AK; Lindhardt TB; Gislason GH; Torp-Pedersen C; Ruwald MH
J Am Geriatr Soc; 2019 Oct; 67(10):2023-2030. PubMed ID: 31339174
[TBL] [Abstract][Full Text] [Related]
23. Emergency Department Management of Atrial Fibrillation and Flutter and Patient Quality of Life at One Month Postvisit.
Ballard DW; Reed ME; Singh N; Rauchwerger AS; Hamity CA; Warton EM; Chettipally UK; Mark DG; Vinson DR;
Ann Emerg Med; 2015 Dec; 66(6):646-654.e2. PubMed ID: 26033532
[TBL] [Abstract][Full Text] [Related]
24. Current management of symptomatic atrial fibrillation.
Haghi D; Schumacher B
Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
[TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?
Reiffel JA; Naccarelli GV
Clin Cardiol; 2006 Mar; 29(3):97-102. PubMed ID: 16596830
[TBL] [Abstract][Full Text] [Related]
27. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
28. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
[TBL] [Abstract][Full Text] [Related]
29. Management of atrial fibrillation in the Greek healthcare setting.
Karampli E; Athanasakis K; Ollandezos M; Pavi E; Kyriopoulos J
Hellenic J Cardiol; 2012; 53(4):273-8. PubMed ID: 22796814
[TBL] [Abstract][Full Text] [Related]
30. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
[TBL] [Abstract][Full Text] [Related]
31. Complexity of atrial fibrillation patients and management in Chinese ethnicity in routine daily practice: insights from the RealiseAF Taiwanese cohort.
Wang KL; Wu CH; Huang CC; Wu TC; Naditch-Brûlé L; Steg PG; Lin SJ; Chiang CE
J Cardiol; 2014 Sep; 64(3):211-7. PubMed ID: 24602451
[TBL] [Abstract][Full Text] [Related]
32. Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.
Zhang H; Yang Y; Zhu J; Shao X; Liu Y; Zhao L; Yu P; Zhang H; He Q; Gu X
Intern Med J; 2014 Aug; 44(8):742-8. PubMed ID: 24893684
[TBL] [Abstract][Full Text] [Related]
33. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
[TBL] [Abstract][Full Text] [Related]
34. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
Allen LaPointe NM; Governale L; Watkins J; Mulgund J; Anstrom KJ
Am Heart J; 2007 Nov; 154(5):893-8. PubMed ID: 17967595
[TBL] [Abstract][Full Text] [Related]
35. Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II).
Andrade JG; Connolly SJ; Dorian P; Green M; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
Heart Rhythm; 2010 Sep; 7(9):1171-7. PubMed ID: 20430112
[TBL] [Abstract][Full Text] [Related]
36. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
[TBL] [Abstract][Full Text] [Related]
37. Patient outcomes according to adherence to treatment guidelines for rhythm control of atrial fibrillation.
Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Vaghasia N; Adelstein E; Jain SK; Saba S
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25845930
[TBL] [Abstract][Full Text] [Related]
38. A survey on the treatment of atrial fibrillation in South Africa.
Jardine RM; Fine J; Obel IW
S Afr Med J; 2014 Jun; 104(9):623-7. PubMed ID: 25212404
[TBL] [Abstract][Full Text] [Related]
39. Ibutilide for treatment of atrial fibrillation in the emergency department.
Viktorsdottir O; Henriksdottir A; Arnar DO
Emerg Med J; 2006 Feb; 23(2):133-4. PubMed ID: 16439743
[TBL] [Abstract][Full Text] [Related]
40. Association between clinical outcome and antiarrhythmic treatment in heart failure patients who have atrial fibrillation upon admission to the hospital.
Watanabe E; Arakawa T; Okuda K; Yamamoto M; Ichikawa T; Harigaya H; Sobue Y; Ozaki Y
J Cardiol; 2012 Jul; 60(1):31-5. PubMed ID: 22445595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
